About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(tetO-Csnk1d)#Mfla
transgene insertion, Marc Flajolet
MGI:4452236
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-Csnk1d)#Mfla/0
involves: 129/Sv * C57BL/6 MGI:4452245


Genotype
MGI:4452245
cx1
Allelic
Composition
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-Csnk1d)#Mfla/0
Genetic
Background
involves: 129/Sv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Camk2a-tTA)1Mmay mutation (7 available)
Tg(tetO-Csnk1d)#Mfla mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
N
• mice exhibit normal social and circadian behaviors
• mice exhibit a 40 minute delay in D-amphetamine-induced hyperlocomotion compared with similarly treated wild-type mice
• D-amphetamine-treated mice exhibit a dose dependent suppression of vertical activity unlike similarly treated wild-type mice that exhibit an increase in vertical activity
• in a dark-light choice test, mice exhibit increased rearing in the light compartment compared with wild-type mice
• in an elevated place maze, mice spend more time in the open arms than wild-type mice
• in a novelty suppressed feeding paradigm, mice exhibit shorter latency to feeding compared with wild-type mice
• however, mice exhibit normal anxiety-related behavior in an open field, forced swim, and tail suspension tests
• mice exhibit a 40 minute delay in D-amphetamine-induced hyperlocomotion compared with similarly treated wild-type mice
• D-amphetamine-treated mice exhibit a dose dependent suppression of vertical activity unlike similarly treated wild-type mice that exhibit an increase in vertical activity
• in an open field test, mice exhibit increased vertical activity compared with wild-type mice
• increased activity begins at 6 weeks of age and persists at least until 16 months of age
• however, treatment with methylphenidate or haloperidol suppresses vertical activity
• in an open field test, mice exhibit increased horizontal and vertical activity compared with wild-type mice
• increased activity begins at 6 weeks of age and persists at least until 16 months of age
• however, treatment with methylphenidate or haloperidol decreases activity levels
• in an open field box, mice fail to build a nest unlike wild-type mice

nervous system
• protein expression of dopamine receptors 1 and 2 and NMDA receptors are decreased in the striatum compared to in wild-type mice

homeostasis/metabolism
• MK801-treated mice exhibit a more rapid onset of increased horizontal activity and decreased vertical activity compared with similarly treated wild-type mice

Mouse Models of Human Disease
OMIM ID Ref(s)
Attention Deficit-Hyperactivity Disorder; ADHD 143465 J:158611





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
04/26/2016
MGI 6.03
The Jackson Laboratory